ZeptoMetrix™ Corporation (ZMC) Announces the Release of Additional Zika Virus Lysates to its Expanding Product Catalogue

Enhancing its existing NATtrol™ Zika Molecular Quality Controls, Inactivated Zika Stock, Culture Fluid and Lysate Product Offerings, ZeptoMetrix is expanding its Zika Catalogue to include 3 additional Zika virus Lysates.

Buffalo,NY

ZeptoMetrix™ Corporation (ZMC) announced today the release of 3 additional Zika virus Lysates to its product inventory to assist in the rapid development of diagnostic tests and for the manufacture of effective and dependable QC materials.

“With our current Zika virus emergency, ZeptoMetrix is steadfast in its continued commitment to fully support the diagnostics industry with as many precise, dependable and non-infectious tools as we can”, explains Dr. Gregory R. Chiklis, President and CEO of ZeptoMetrix.

Strengthening its considerable Tropical Disease offerings (https://www.zeptometrix.com), ZeptoMetrix has introduced the following Zika virus Lysates to its Zika product line:

Zika Virus (Strain: PRVABC59) Lysate (1 mg) – # 0810525

< | >